Quality system
A certified quality system is the framework for ensuring excellence in service delivery.
We take the quality and integrity of our research seriously. The investment in our quality system is a demonstration to you, our customers, of our commitment to provide you with the best possible experience when working with us as your research vendor, as well as, constantly improving the services we provide.
Our quality system results in direct benefits to your project.
The globally-recognized ISO 9001:2015 certification from NSF-ISR represents our commitment to quality and, ultimately, our customers. Achieving certification is a demanding process that includes a rigorous audit to demonstrate conformance to quality assurance and information security standards.
Highly trained researchers skilled in the execution of many research methods.
A streamlined onboarding of Bold Insight as a service provider.
A commitment from our entire organization to adhere to quality-controlled processes and information security practices.
Particularly in the medical device UX and HF space, organizations find it easier to work with ISO-certified partners because it demonstrates a commitment to continuous improvement in the delivery of services.
About NSF-ISR
Internal and external training
We invest heavily in the development of expert UX and HF practitioners. All of our researchers go through a robust internal training program prior to their first project, and benefit from our apprenticeship model as well as plentiful external training opportunities.
Industry best practices
We don’t just adhere to best practices, we work with other industry thought leaders to define them through our corporate sponsorships and participation with AAMI and other organizations:
Bold Insight presents on AI and remote testing at UX Masterclass
Bold Insight Managing Partners Bob Schumacher and Gavin Lew will present at the 16th UX Masterclass on December 4-5, 2020. This year, the conference will be held virtually and is hosted by...
5 tips to mitigate use-related risk for pre-filled syringes and other injection devices
With years of experience conducting human factors research with injection devices, we wanted to share some data-driven insights to those involved in the product development for these devices. We...
Bold Insight to connect with medical device manufacturing community at Pre-Filled Syringes East Coast virtual conference
Attended by drug and drug-delivery device developers, medical device engineers, and smart device and packaging developers, SMI’s 7th Pre-Filled Syringes East Coast conference will be held virtually...
Bold Insight presents on AI and remote testing at UX Masterclass
Bold Insight Managing Partners Bob Schumacher and Gavin Lew will present at the 16th UX Masterclass on December 4-5, 2020. This year, the conference will be held virtually and is hosted by PeepalDesign and UXalliance. The conference theme, The Changing Faces of UX: Global perspectives, will...
5 tips to mitigate use-related risk for pre-filled syringes and other injection devices
With years of experience conducting human factors research with injection devices, we wanted to share some data-driven insights to those involved in the product development for these devices. We have pulled together five research and design tips to mitigate use-related risk for injection devices:...
Bold Insight to connect with medical device manufacturing community at Pre-Filled Syringes East Coast virtual conference
Attended by drug and drug-delivery device developers, medical device engineers, and smart device and packaging developers, SMI’s 7th Pre-Filled Syringes East Coast conference will be held virtually October 26-27, 2020. A leader in the medical device human factors industry, Bold Insight will host a...
